abbott labortories
TRANSCRIPT
ABBOTT LABORTORIES
Position of Abbott in the world :
Introduction:
Abbott Laboratories is a diversified pharmaceuticals health care company. It has 68,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, located near North Chicago, Illinois.
Abbott Laboratories was founded by Chicago physician Wallace Calvin Abbott in 1888. In 2007, Abbott had over $25 billion in revenue.
Abbott's core businesses focus on pharmaceuticals, medical devices and nutritional products, which have been supplemented through several notable acquisitions. It has also divested itself of less profitable businesses through sales and spinoffs.
In 2001, Abbott acquired Knoll, the pharmaceutical division of BASF.In 2004, Abbott spun off its hospital products division into a new 14,000 employee company named Hospira, and acquired TheraSense, a diabetes care company, which it merged with its MediSense division to become Abbott Diabetes Care. In 2006, Abbott assisted Boston Scientific in its purchase of Guidant Corporation. As part of the agreement, Abbott purchased the vascular device division of Guidant.
In January 2007, Abbott Laboratories agreed to sell its in vitro diagnostics and Point-of-Care diagnostics divisions to General Electric for more than $8 billion. These units were slated to be integrated into the GE Healthcare business unit. The transaction was approved by the Boards of Directors of Abbott and GE and was targeted to close in the first half of 2007. However, on July 11th, 2007, Abbott announced that it had terminated its agreement with GE because both parties could not agree on terms of the deal.
On September 8th, 2007, Abbott completed the sale of the UK manufacturing plant at Queenborough to Aesica Pharmaceuticals, a Private equity-owned UK manufacturer. No announcements have been made restricting the movement of staff to Abbott unlike other sell outs.
Some of the important details of Abbott are:
Type Public
Founded 1888
HeadquartersAbbott Park, North Chicago, Illinois, USA
Chairman and CEO Miles D. White,
ProductsPharmaceutical products, medical devices, diagnostic assays, nutritional products and animal health products
Employees 68,000
Divisions: Abbott works for healthcare through various divisions. The divisions or the area of expertise of Abbott are:
Anesthesia.
Animal Health.
Anti-Infectives.
Cardiovascular.
Diabetes Care.
Hematology.
Immunodiagnostics and Clinical Chemistry.
Immunology.
Metabolics.
Molecular.
Neuroscience.
Nutrition.
Oncology.
Pain Care.
Point of Care.
Renal Care.
Spine.
Vascular.
Virology.
Products:
Some of the key products produced by Abbott Laboratories include:
Pharmaceuticals:
Biaxin/Klacid (clarithromycin) Depacon (valproic acid) Depakote (valproate semisodium) Gengraf (cyclosporin) Gopten/Mavik (trandolapril) Humira (adalimumab) Isoptin (verapamil) Hytrin (terazosin) Kaletra (lopinavir/ritonavir) Meridia/Reductil (sibutramine) Norvir (ritonavir) Omnicef (cefdinir) Synthroid (levothyroxine) Tarka (trandolapril/verapamil) Tricor (fenofibrate) Ultane (sevoflurane)
Niaspan (niacin) Azmacort (triamcinolone) Simcor (niacin/simvastatin) Advicor (niacin/lovastatin) Valcote Simdax (levosimendan) - not approved in US
Nutrition
Similac-LF (Infant milk powder Lactose free) Ensure Pedia Sure Gain (infant formula milk)
Diagnostics
FreeStyle Freedom Blood Glucose Monitor FreeStyle Flash Blood Glucose Monitor FreeStyle Lite Blood Glucose Monitor FreeStyle Navigator Continuous Blood Glucose Monitor
Automated analyzers
Abbott Axsym Abbott Aeroset Abbott CELL-DYN (Complete blood count analyzer)
Abbott manufactures fully automated random access automated analyzers utilized by medical technologists in medical laboratories. Abbott also provides client support for these instruments.
Abbott is a company that focuses on turning science into caring. Its branch in India- Abbott India Ltd has been serving the needs of Indian consumers over the past many decades with the products backed by science. Abbott India has a network of 18 distribution points, which cater to 11,000 stockists and 70,000 retailers.
Abbott India Ltd provides healthcare solutions through its four business units:
1. Primary Care, which markets products in the areas of Pain Management, Gastroenterology, with well-known brands like Brufen, Digene, Cremaffin.
2. Specialty Care – Metaboloics & Urology provides solutions in the areas of Thyroid, Obesity, Diabetes and Benign Prostratic Hyperplasia.
3. Specialty Care - Neuroscience has a varied portfolio, with specialty products in the Neurology and Psychiatric segments.
4. Hospital Care, offers products in the field of anesthesiology and neonatology namely Forane, Sevorane and Survanta.
It’s headquarter in India is at Mumbai. In India its business has expanded to Delhi, Bangalore, Kolkata, Chandigarh, Chennai, Hyderabad, Vellore, Guwahati, Lucknow, Patna, Indore, Ahmedabad, Jaipur, Cuttak, Raipur, Ranchi and Goa.
Products:
The products of Abbott India Ltd presently in the market and enjoying market share are as follows:
Betonin ASTBetonin XT
BrufenBrufen MR
Brufen SoftraClivarine
CremadietCremaffin
Cremaffin PlusCremalaxDigeneEnsure
Entamizole PlusEpilex Chrono
EptoinEptoin Injection
ForaneGanaton
Ganaton TotalGanaton OD
Hytrin
Klacid I.V.Leptos
Lucrin DepotNausidome
ObimetOptium
Obimet-GXPediasureProthiadenProtussaRevilife
SevoraneSurbex XTSurvantaThyrocab
ThyronormThyrowel
UlcikitZolfreshZonicareZyrem
Business of Abbott in the World
The business of Abbott Laboratories in the world has been increasing from year to year and has shown a growth of around 15.3 % in the year 2007.
Its sales increased from $22.3 billion in the year 2006 to $25.9 billion in the year 2007 and it is expected to increase further in the future by a great margin.
The contribution in sales of Abbott is from all its divisions, but the greater contribution is from pharmaceutical division. The pharmaceutical division contributes more than 50% of the total sales.
The business of Abbott is growing in the world and it has been ranked amongst the top 50 pharmaceutical companies in the world. Abbott’s business has been growing worldwide and its U.S. sales have been less than its international sales in the year 2007. For the first time the revenues outside the United States exceeded those within.
Bar diagram:
16.218.1
2022.3
25.9
0
5
10
15
20
25
30
2003 2004 2005 2006 2007
Years
Sale
s (
in b
illi
on
do
llars
)
Fig.: Sales of Abbott Laboratories in the world from year 2003 to year 2007
The above graph shows that year by year the sales of Abbott Laboratories in the world have been increasing. While it was $16.2 billion in the year 2003, it increased every year and in the year 2007 it went up to reach $25.9 billion.
Pie chart:
Sales by major operating segments
4.4
3.2
3.1
14.6
0.6
Nutritional products
Diagnostics
Medical devices
Pharmaceuticals
Others
Fig.: Segment wise sales of Abbott
The pie chart above shows that greater part of the sales of Abbott is contributed by pharmaceutical division. It has contributed about $14.6 billion out of total $25.9 billion in 2007 sales. Nutritional products contributed around $4.4 billion of sales.
Business of Abbott India Ltd.
The business of Abbott in India is flourishing and is growing very fast. Year by year its sales are increasing. As far as the profit is concerned, though it decreased in the year 2004-05, but after that again started rising every year.
The sales of Abbott India Ltd. was about Rs. 3549.7 million in the year 2001-02 which rose to Rs.3731.2 million in the year 2002-03 and it continued increasing every year and in the year 2006-07 it went up to Rs.6361.2 million.
3549.7 3731.24050.7
4446.7
5405
6361.2
0
1000
2000
3000
4000
5000
6000
7000
2001-02 2002-03 2003-04 2004-05 2005-06 2006-07
Years
Sal
es (i
n R
s. m
illio
ns)
As for profit of Abbott India, it earned a profit of Rs.847.7 million in the year 2001-02 which up to Rs.1374.5 million in the year 2003-04. But it fell to just Rs.871.1 million in the year 2004-05. After that it again started going up and went up to Rs. 874.4 million in the year 2005-06 and Rs.1018.6 million in the year 2006-07.
847.7950.6
1374.5
871.1 874.41018.6
0
200
400
600
800
1000
1200
1400
1600
2001-02 2002-03 2003-04 2004-05 2005-06 2006-07
Years
Pro
fit (i
n R
s. m
illio
ns)
Abbott India Ltd. is earning a good amount of profit today and is one of the leading pharmaceutical companies in India today.
Hospitals covered under this project
In this project I have covered the 4 big corporate hospitals of Chennai. These 4 hospitals and their brief details are as follows:
Vijaya Hospital is one among the earliest private hospitals to come into being in the city, which is the first of the three hospitals of the Vijaya Medical & Educational Trust was started in 1972 with just 60 beds and 125 staff. It was founded by Shri. B. Nagi Reddy. Due to the facilities offered and the quality of service rendered, the hospital has steadily grown in size as well as popularity resulting in expansion, which has become a matter of continuous necessity. Vijaya hospital by its untiring medical service has grown in size as well as popularity. Vijaya hospital now consists of 300 beds and 9 operating theatres.
The procedure of work in Vijaya hospital: 1. Monday to Saturday.
2. Meeting Time – 10:00 A.M. – 5:00 P.M.
The various departments which were covered here are
Department of Psychiatry.Department of Neurosurgery.Department of Nephrology.Department of Medicine.Department of General Surgery.Department of Plastic Surgery.Department of Medical Gastroenterology.Department of Surgical Gastroenterology.Department of Vascular Surgery.Department of Gynecology.Department of Urology.Department of Radiology.Department of Dermatology.
Department of Ophthalmology.Department of ENT.
The steady growth and popularity of Vijaya Hospital and raising demand for private health care brought about the need for
expansion of Vijaya Hospital. This resulted in the establishing of Vijaya Health Centre (VHC) in 1987 with 25 inpatient beds.
Now Vijaya Health Centre is one of the largest health care providers in south India with 300 beds and is equipped with all latest equipments. It has a comprehensive range of inpatient and
outpatient medical facilities and services.
VHC not only serves the patients of India but also patients from various parts of Asia, Africa, Far East and the Middle East
In addition to the inpatients accommodation 20 rooms are available with facilities for stay and boarding for the convenience of attendants of patients coming from outside
Chennai. The most important equipment the hospital possesses is its team of specialists each of whom is reputed in his/her field.
The procedure of work in Vijaya hospital: 1. Monday to Saturday.
2. Meeting Time – 10:00 A.M. – 5:00 P.M.
The departments covered here are:
Department of Psychiatry.Department of Neurosurgery.Department of Nephrology.Department of Medicine.Department of General Surgery.Department of Plastic Surgery.Department of Medical Gastroenterology.Department of Surgical Gastroenterology.Department of Gynecology.Department of Urology.Department of Radiology.Department of Dermatology.
Department of ENT.Department of Cardiology.
Department of Endocrinology.Department of Orthopedics.Department of Oncology.Department of Radiology.Department of Surgical Oncology. Department of Urology.
.
Vijaya Heart Foundation was formed as an extension of Vijaya Health Centre in 1996 with 100 inpatient beds. The secondary and tertiary cardiac services both in India and abroad have been marked by rapid expansion and escalating costs. To address this VIJAYA HEART FOUNDATION has been created to make basic and advanced cardiac care affordable and available round the clock. This was started to keep in pace with the growing demand for highly sophisticated "State of Art" Cardiology and Cardiothoracic surgical services.
The procedure of work in Vijaya hospital: 1. Monday and Friday.
2. Meeting Time – 11:00 A.M. – 3:00 P.M.
The various departments which were covered here are:
CardiologyInternal & Critical Care MedicineCardio Thoracic Surgery.
Vascular Surgery.
Centrally Monitored Intensive Care Unit (30 Beds)
Twin Cardiac Surgery Theatres with 20 Bedded Post OP ICU.
Sri Ramachandra Medical Centre
Sri Ramachandra Medical Centre (SRMC) is a tertiary care multi-specialty university hospital. Today, SRMC is a leader in the art care for over 3000 patients who walk through its portals daily and many more who
seek remote healthcare through its connectivity and telemedicine services. With over 1500 beds, 114 ICU beds, 25 operating rooms and a campus spread over 175 acres. SRMC is one of the largest private healthcare facility in South Asia. SRMC is committed to providing the highest quality of patient care while ensuring safe effective healthcare. Through innumerable continuing education programs, in-services, and quality and safety improvement processes, the facility is able to provide affordable healthcare at world class standards
The departments covered in this hospital are:
Department of Neurology.
Ranbaxy is India's largest pharmaceutical company with a 2007 turnover of Rs 4,198.96 crores (Rs 41.989 billion) by sales. It is one among the top 20 pharmacy companies in the world.
2. Dr. Reddy's Laboratories Dr Reddy's Labs, with a 2007 turnover of Rs 4,162.25 crores (Rs 41.622 billion), is India's second largest drug firm by sales.
3. Cipla Pharma major Cipla is India's third largest pharmaceutical firm. Its 2007 revenues stood at Rs 3,763.72 crores (Rs 37.637 billion).
4. Sun Pharma Industries The Dilip Sanghvi-led Sun Pharma is the nation's 4th largest pharma company at 2007 revenue Rs 2,463.59 crores (Rs 24.635 billion).
5. Lupin Labs Lupin Labs is India's 5th largest drugs firm. Its 2007 revenue was at Rs 2,215.52 crores (Rs 22.155 billion).
6. Aurobindo Pharma Aurobindo is India's 6th largest pharma firm by sales. Its 2007 revenues stood at Rs 2,080.19 crores (Rs 20.801 billion).
7. GlaxoSmithKline Pharma GSK is India's 7th largest drug company with a turnover of Rs 1,773.41 crores (Rs 17.734 billion) for 2007.
8. Cadila Healthcare Cadila's 2007 revenue was Rs 1,613.00 crores (Rs 16.13 billion), which makes it India's 8th largest pharma firm.
9. Aventis Pharma Aventis Pharma, with a revenue of Rs 983.80 crores in 2007 (Rs 9.838 billion) is the 9th largest Indian drug company.
10. Ipca Laboratories At a revenue of Rs 980.44 crores (Rs 9.804 billion), Ipca is India's 10th largest pharma firm by sales